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Positron emission tomography/magnetic resonance imaging (PET/MRI) potentially offers several
advantages over positron emission tomography/computed tomography (PET/CT), for example, no
CT radiation dose and soft tissue images from MR acquired at the same time as the PET. However,
obtaining accurate linear attenuation correction (LAC) factors for the lung remains difficult in PET/
MRI. LACs depend on electron density and in the lung, these vary significantly both within an indi-
vidual and from person to person. Current commercial practice is to use a single-valued population-
based lung LAC, and better estimation is needed to improve quantification. Given the under-appreci-
ation of lung attenuation estimation as an issue, the inaccuracy of PET quantification due to the use
of single-valued lung LACs, the unique challenges of lung estimation, and the emerging status of
PET/MRI scanners in lung disease, a review is timely. This paper highlights past and present meth-
ods, categorizing them into segmentation, atlas/mapping, and emission-based schemes. Potential
strategies for future developments are also presented. © 2019 The Authors. Medical Physics pub-
lished by Wiley Periodicals, Inc. on behalf of American Association of Physicists in Medicine.
[https://doi.org/10.1002/mp.13943]
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1. INTRODUCTION
The combined imaging modality positron emission tomogra-
phy/magnetic resonance imaging (PET/MRI) offers several
advantages over PET/computed tomography (CT). These
include a superior soft tissue contrast, reduced radiation
exposure, increased functional information (including perfu-
sion and spectroscopy), MRI-based motion correction, as
well as providing approximately simultaneous rather than
sequential acquisitions.1,2 Using MRI can also circumvent
artifacts from the iodinated contrast agents potentially used in
CT and the attenuation map mismatch between the often sin-
gle-respiratory phase CT, and multi-respiratory phase PET.3,4
To fully exploit the benefits of these hybrid systems, it is
essential to be able to obtain quantitative information from
the PET images. This requires access to a map of the electron
density in order to correct for attenuation of the PET photons.
Attenuation can be modelled via the Lambert Beer law, with
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associated linear attenuation coefficients (LACs).5 In stand-
alone PET systems, measurements of LACs can be performed
directly from PET transmission scans and should yield
ground-truth LACs. In contrast, PET/CT scanners use CT for
faster and less noisy attenuation correction. Here, the LACs
determined with 60–80 keV photons from CT are converted,
using bilinear scaling, to the corresponding LAC values for
the PET 511 keV photons.6 Tabulated compositions can be
used as an alternative to bilinear scaling, but Martinez and
Calzado7 found no relevant difference for bones and lung.
Alternatives include trilinear scaling,8 the quadratic polyno-
mial calibration curve,9 and (virtual-) dual energy CT meth-
ods.10,11 Although a toroidal transmission source has been
demonstrated for evaluation of attenuation coefficient mea-
sures,12 the limited space within the scanner bore and the
need to measure over the whole-lung volume prevent use of
transmission sources during clinical imaging. This view is
supported by the work of Bowen et al.13 who stated that their
developed transmission scan method is not for routine subject
imaging, and by the study of Mollet et al.14 who noted that
the reduced diameter of the PET/MR system would affect the
PET count rate performance of the simultaneous emission/
transmission scan. As a consequence, MRI is used (at least in
part) for determining attenuation coefficients. Such attenua-
tion factors should perhaps be compared to those determined
using PET transmission scans as stated by Schramm et al.15
However, this is becoming increasingly difficult due to the
limited availability of PET transmission scans. Therefore,
comparison to CT-derived LACs is most commonly per-
formed in the literature.
In recent years, a number of review papers have been pub-
lished describing attenuation estimation.3,4,16–20 Keereman
et al.3 published an overview of the various techniques, cate-
gorizing them into MRI derived (template and voxel-based),
transmission, and emission-based methods. The descriptions
were focused on both the brain and whole body, as were
those in the review presented by Martinez-M€oller and
Nekolla.4 Mehranian et al.16 also reviewed attenuation estima-
tion methods, summarizing them into segmentation, atlas
registration and machine learning, and emission/transmission
types. They stated the advantages and disadvantages of each
class of technique, again for the brain and whole body. The
authors also noted various challenges and potential solutions
associated with attenuation correction, for example, MRI
truncation compensation, MRI coil and other device attenua-
tion, and optimized MRI data acquisition. To our knowledge,
this has been the only review paper to explicitly separate lung
attenuation from whole-body techniques. It categorized meth-
ods into those that predict mean lung LACs from mean MRI
intensity and/or lung volume, atlas-based registration and
learning schemes, and emission-based estimation. However,
the summary given was not exhaustive, only representing less
than one page in total. Remaining reviews did not distinguish
the lungs from whole-body methods. Bezrukov et al.17
focused on attenuation estimation using MR data. Hofmann
et al.18 reviewed methods for the brain and torso (but not the
lung specifically). Finally, Wagenknecht et al.19 described
template, atlas, direct segmentation from T1-weighted MRI,
and sequence-based approaches to attenuation estimation,
using an intermix of both brain and whole-body results. They
stated the advantages and disadvantages of different tech-
niques, along with the challenges of MRI-based attenuation
estimation. From the combined reviews, it is evident that lung
attenuation estimation has been significantly under-
represented, in terms of summarizing past, and present
techniques, as well as highlighting potential methods and
direction for subsequent improvement.
Inaccurate LACs in PET reconstruction can result in PET
quantification errors.21 Current PET/MRI scanners use con-
stant, population-based LACs assigned following segmenta-
tion of the whole-lung from MR images. The MRI signal is
not directly related to photon attenuation, and therefore pre-
defined values for LACs are used.19 This is an approximation
because lung tissue exhibits variation both within an individ-
ual, between respiratory states, and from person to person.
After incorporating the resultant magnetic resonance attenua-
tion correction (MRAC) maps into reconstruction, PET quan-
tification in the form of standard uptake values (SUVs) is
well-known to be affected. For example, Seith et al.21 deter-
mined that using constant lung LAC values in non-Time-of-
Flight (ToF) PET/MRI underestimated mean SUV in lung tis-
sue regions of interest (ROIs) by 9% in the posterior lung
region and over-estimated by 6% in the anterior and middle
lung, relative to PET/CT. For pulmonary studies, Holman
et al.22 quantified the effect on both Standard Uptake Values
(SUVs) and various kinetic parameters of using LACs corre-
sponding to a single breathing state to reconstruct ungated
PET data, without TOF, finding errors of up to 30%. It is
therefore likely that this error would be even larger when
using a fixed population value when studying the diseased
lung. The authors determined that respiratory induced mis-
matches (albeit for PET/CT) affect PET lung quantification
with the error being influenced by both the type of tracer and
the time since tracer administration. It is thus important that
improved lung attenuation estimation is achieved. There is
potential for PET/MRI to have an increased role in oncology
with lung tumors currently forming a significant focus of
PET/CT studies.23 In addition, there is increased interest in
using PET to study pulmonary diseases.24 Improved lung
attenuation estimation is also highly relevant in both nodular
and diffuse lung disease.
Given the under-appreciation of lung attenuation estima-
tion as an issue, the inaccuracy of PET quantification due to
the use of single-valued lung LACs, the unique challenges of
lung estimation (later stated in Section 3), and the emerging
status of PET/MRI scanners in both nodular and diffuse lung
disease, this review seeks to outline technologies for
improved lung LAC determination.
The required accuracy for lung attenuation estimation will
depend upon application. For example, higher accuracy is
likely to be needed if quantifying regional uptake in the dis-
eased lung, than for SUV quantification in tumors, assuming
that the tumor area has been correctly identified as soft tissue
in the MRAC. Where possible, we highlight the implication
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of LAC variance on SUV variation for either the whole lung,
or on a voxel-by-voxel basis, using maximum and average
values. Quantitative accuracy of the reviewed techniques is
predominantly assessed by comparing attenuation estimation
with a CT-based reference standard. The use of non-FDG
radionuclides is also reported where information is available.
2. CLINICAL MOTIVATION
The correct method of attenuation estimation can have
notable impact in clinical routine potentially allowing for
diminished respiratory artifacts, fewer susceptibility artifacts,
improved lesion/disease detectability, and higher accuracy
SUV quantification. Inaccurate estimation can complicate the
assessment of PET findings and lead to false negative or false
positive results. For lung imaging, radiologists often have to
diagnose or follow-up the presence of small pulmonary nod-
ules, for which the correct morphological and metabolic
assessment can be overwhelming. Furthermore, new thera-
pies for lung cancer may not change tumor size as a conse-
quence of their action, instead influencing the metabolism of
the lesion. Correct metabolic quantification and appropriate
attenuation estimation is therefore highly desirable.
PET/MRI of the lung can be of value for improved patient
care compared with PET/CT. Advantages are predominantly
the use of an MRI component for dose reduction, tissue char-
acterization, and limited discomfort in patients who require a
double exam (PET and MRI). The main application of the
MRI component in the lung is the evaluation of soft tissues
of the thoracic wall, for example, tumors of the lung apex
infiltrating the nervous structures, in the assessment of medi-
astinal structures, that is, thymoma, thymic carcinoma, or, in
all conditions affecting the posterior mediastinum with possi-
ble infiltration/assessment of the spine and nervous roots.
There are also potential benefits in doing multiparametric
PET/MRI, as demonstrated in Figs. 1 and 2.
There are three main domains where accurate AC in a
PET/MRI machine is in great demand.
The first area is oncological applications which have pri-
marily been investigated to compare the reproducibility in
quantification between PET/CT and PET/MRI. The second
aspect is the correct assessment of lung inflammation, both
for chronic and acute lung disorders. It is known that PET
has demonstrated high standard uptake values (SUVs) of 18F-
fluorodeoxyglucose (FDG) in fibrotic lung disease. The
assessment of “fibrotic” and “normal lung” becomes
essential as it has been shown that regions that appear struc-
turally normal also appear to have higher SUV, suggesting
that the disease can already be present, even if not visible,
with other modalities (ie CT) and may precede future regions
of macroscopic structural change or deterioration of many
forms of Interstitial lung disease (ILD).25 In this regard, accu-
rate regional quantification appears even more important than
in the focal pathology (eg lung nodule, cancer), since the
metabolic activity can be used for na€ıve assessment and lon-
gitudinal studies to monitor possible treatments.26 In addi-
tion, estimation of, and correction for, the regional air
fraction, which can be obtained from density maps, is impor-
tant to be able to characterize different lung diseases.27
Finally, the reproducibility of parameters needs to be consis-
tent in the light of further image analysis of radiomic features
such as textural information and inaccurate lung attenuation
estimation may mislead or influence the values of radiomic
features.
It is expected that PET/MRI will improve clinically, in
part, because lung MR imaging is advancing to address its
main challenges including low signal, image artifacts, and
lack of bone-lung tissue contrast. Lung MRI is likely to be
important for both improved LAC estimation and as part of a
patient’s general PET/MRI exam. From a clinical perspective,
MRI offers promise, particularly given its value in mediasti-
nal mass characterization and cystic fibrosis.28–30
MRI sequences that improve clinical information and/or
aid attenuation correction estimation include spoiled gradient
echo (FLASH, SPGR, FFE) sequences, for which two or three
dimensional acquisitions can be performed, with or without
contrast and/or fat suppression.31 They may also include bal-
anced steady state free precession (bSSFP — TrueFISP,
FIESTA, BFE) or single-shot fast spin echo (RARE/HASTE,
Turbo FSE) sequences, both of which are routinely used in
pulmonary MRI.31 Diffusion-weighted imaging (DWI) may
additionally be of value, although its use in lung imaging is
less established, for example, as a result of a lack of agreement
in the apparent diffusion coefficient (ADC) cut-off values
between benign and malignant masses.32 Short tau inversion
recovery (STIR) sequences may also be used, such as in imag-
ing lung cancer or mediastinal metastases.33 Other advances
may arise from multi-parametric MRI, for example, in the
combination of DWI and dynamic contrast imaging (DCE)
for lung cancer imaging.34 In addition, both motion-compen-
sated imaging, such as, using self-navigated sequences or fast
Fourier decomposition MRI for noncontrast-enhanced
FIG. 1. Multiparametric positron emission tomography (PET)/magnetic resonance imaging in a left upper lobe lung mass. T2 weighted and DW (diffusion
weighted) images identify the tissue heterogeneity and the increased signal is related to increased tissue cellularity. Neovascularization is seen on the dynamic
contrast-enhanced (DCE) perfusion sequence. Fluorodeoxyglucose PET signal confirms the elevated glucose consumption, a typical pattern of primary lung
neoplasms.
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ventilation and perfusion weighting may lead to higher quality
lung imaging.29
With the extremely short T2* (of order 0.5–3 ms) relax-
ation times in the lungs, MRI sequences with near-zero echo
times are very promising.35 This gives the potential for
detecting lung signal despite the rapid signal decay. Such
sequences include UTE, SWIFT, ZTE, WASPI, SPRITE,
PETRA, and AWSOS.35
In the brain, UTE attenuation estimation has shown suc-
cess, for example, Jang et al.36 established a dual-echo
ramped encoding sequence (acquiring UTE and out-of-phase
images with the first and second echoes, respectively) to seg-
ment fat, water, air, and bone. To transfer such methods to the
moving, larger lung FOV, under-sampling schemes will need
to be implemented, and therefore, advanced methods, includ-
ing parallel imaging, compressed sensing, and machine learn-
ing may be necessary.
In the lung, there have been a variety of different UTE/
ZTE studies aimed at imaging rather than LAC estimation.
As examples, Herrmann et al.37 optimized a three-dimen-
sional (3D) UTE sequence both shortening the repetition time
and providing automatic gradient delay compensation. Dour-
nes et al.38 produced submillimeter imaging of the lung using
pointwise encoding time reduction with radial acquisition
(PETRA), and this has also been assessed against a UTE
sequence in the lung.39 Nazaran et al.40 utilized T2* UTE
mapping in the lung. Delacoste et al.41 performed UTE imag-
ing with advanced reconstruction on cystic fibrosis patients.
Feng et al.42 undertook four-dimensional (4D) respiratory
motion-resolved sparse lung MRI. Finally, Jiang et al.43 per-
formed 3D image navigation using five-minute-free breathing
UTE scans to improve resultant image motion robustness.
Such sequences may offer improved lung contrast com-
pared with conventional sequences, potentially allowing for
better lung segmentation (and the detection of bone) and
improved lung density estimation. However, they suffer long
acquisition times and ideally should also be 4D to reduce the
effect of MR-PET spatial mismatch due to breathing.
There are other nonconventional imaging techniques that
are being explored. Oxygen-enhanced MRI can be used to
shorten lung tissue, blood, and plasma T1 values, potentially
giving ventilation and perfusion MRI weighting,31 although
lung registration between pre and postinhalation datasets is a
challenge.44 Signal can be provided from hyperpolarized
129Xe or 3He gas or inhaled inert fluorinated (19F) gas.44
3. CHALLENGES IN THE LUNG
Performing accurate lung attenuation estimation in PET/
MRI is challenging for many reasons.
Firstly, the required LACs are dependent upon tissue elec-
tron density but the MRI signal is dependent on tissue proton
density and both longitudinal (T1) and transverse (T2 and
T2*) magnetization relaxation times.
Secondly, obtaining high-quality lung MRI can be diffi-
cult. Pulmonary MRI inherently suffers from a low signal
because the lungs have a low tissue proton density (approxi-
mately 10% of other tissues).31 In addition, numerous lung-
air interfaces create magnetic susceptibility differences, and
this causes the T2* relaxation time to be extremely low,
approximately 0.5 ms at 3 T.31 Consequently, lung tissue
MRI signal decays rapidly following radio-frequency excita-
tion. Low parenchymal signal can not only make lung density
difficult to quantify but may make differentiation of lung and
bone (such as within the ribs) unfeasible. This may affect
quantification because despite both having low MRI signal
FIG. 2. Different sequences provide different information. These parameters can be combined with the results found from positron emission tomography/mag-
netic resonance imaging (PET/MRI) (right image), or PET/MRI (not shown) to give an “in vivo” biology of tumor heterogeneity.
FIG. 3. An example of a cardiac ghost artifact propagating into the lung
appearing in the anterior portion of the lung (white arrow), with respiratory
motion artifacts and pathological signal.
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for most sequences, air and bone have very different attenua-
tion properties.2
Pulmonary MRI also commonly suffers from image arti-
facts, including those due to blood flow, a result of the lung’s
high vascularity, and blurring artifacts from cardiac/respira-
tory motion.45 Example artifacts are presented in Figs. 3 and
4. Inadequate MRI quality can result in segmentation and
registration errors that limit the ability to determine continu-
ously valued LACs.
Lung LACs are particularly difficult to quantify because
they vary, both on a regional basis and from person to person.
They show gravitational dependency in the anterior-posterior
direction for a patient lying supine in a scanner, as illustrated
in Fig. 5.21 Indeed, of the segmented tissue classes used in
MRAC, the lungs show the greatest inter-patient variability,
having a reported mean of 0.024 cm146 and standard devia-
tion of 0.004 cm1,16,46–48 with the lung density (quantified
as percentage of pixels in the lung between 750 and
900 HU) varying by up to 30% between patients.16,49 As a
comparison between tissue types, Bezrukov et al.50 deter-
mined standard deviations in LACs of 73.47, 26.60, 5.58, and
17.84 cm1 9 104 for the lungs, fat (hip), muscle, and bone
(femur), respectively, in a pediatric set. In an adult set, the
authors determined corresponding errors of 46.82, 11.30,
5.21, and 17.03 cm1 9 104. Intra- and inter-patient vari-
abilities have been suggested to contribute approximately
equally to PET lung voxel variation when comparing constant
versus continuously valued lung LACs.51
A variety of lung density dependencies have been reported
in the literature making LAC quantification challenging.
Variability in LACs can originate from a variety of different
factors including: gender, height, age, pathological condi-
tions, and respiration pattern.21,49,50,52–57
Disease can impact lung density,58 for example, decreased
lung attenuation typically occurs in emphysema or cystic lung
diseases, whereas focal increased attenuation occurs in fibro-
sis.59 Often, disease can lead to variable lung attenuation, as
shown by example in Fig. 6.
In addition, Karimi et al.49 determined that mean lung
density is significantly higher in smokers with normal pul-
monary function compared to nonsmokers, with females hav-
ing higher density than males, a variation dependant on
height. Bezrukov et al.50 also found after comparing lung
LACs in pediatric and adult cohorts that lung LAC intra-pa-
tient variation in pediatrics is higher, although adults have a
higher mean lung LAC than pediatric patients.
Breathing state can also impact lung attenuation. Lung
density is lower at end-inspiration than end-expiration.57,60
Considering MRAC maps, the MRI signal is higher at end-
expiration, as a result of a higher lung proton density coupled
with less signal dephasing.31 This arises from diminished
susceptibility differences across fewer lung-air interfaces.
Furthermore, the difference in duration between the PET and
MRI scans can create MRI-PET tissue mismatches, leading
to PET “banana” artifacts near the diaphragm. Figure 7 pro-
vides an example of an MRAC artifact in the lower lung.
A final challenge in lung attenuation is the process of
method validation. Comparing different techniques for lung
LAC estimation is nontrivial because of multiple other fac-
tors. For example, the parameters used in PET reconstruction
algorithms, any registration used as part of the attenuation
correction calculation, field of view (FOV) truncation
FIG. 4. Demonstration of magnetic resonance imaging (MRI) respiratory blurring in both a healthy volunteer (top images) and a patient with cystic fibrosis (bot-
tom images). Left versus right images show the improved performance after considering respiration within reconstruction. The MR images were determined using
three-dimensional ultrashort echo time sequences. Adapted from Jiang et al.43
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compensation, coil attenuation, and nonlung tissue attenua-
tion classes can all influence PET quantification.19 Further-
more, given that local PET quantification can be influenced
by signal attenuation along the whole line of response19 it can
be difficult to judge the effectiveness of different methods.
Considering the previously identified challenges, the key
requirements of a lung attenuation estimation technique are
that it should be robust, patient-specific, respiratory-resolved,
and clinically feasible. Good practice should be followed in
the validation process (as further discussed in Section 5) by
considering the effect of other influencing factors, applying
well defined metrics (with reference to PET quantification
and LAC variation), and comparing to either PET transmis-
sion or CT-based attenuation estimation.
4. PAST AND PRESENT ATTENUATION
ESTIMATION METHODS
Attenuation estimation methods for PET/MR can be
divided into three categories; segmentation, atlas/mapping,
and emission-based schemes. These are briefly summarized
in Table I, and each type is then subsequently described in
more detail in this Section. Techniques that aim to reduce
breathing mismatches are also briefly detailed in Section 4.B,
which can affect all three categories.
4.A. Segmentation methods
Segmentation remains the most common form of deter-
mining the LACs, and the main vendors use MR images to
segment the whole lung and then apply a single-valued popu-
lation-based LAC. The number of tissue classes and choice
of LACs depend on the vendor. In the literature, a wide
range of lung values have been used (quoted as
0.018–0.027 cm1).3 Segmentation techniques benefit from
using individual patient data, not requiring large cross-over
datasets (c.f. atlas/learning methods) and being computation-
ally fast. Details of specific vendor MRAC sequences are
shown in Table II. These are all rapid T1-weighted acquisi-
tions and are not designed to specifically image lung tissue.
The Siemens mMR method is based on the two-point 3D
volume-interpolated breath-hold (VIBE) Dixon sequence for
whole-body segmentation. Here, the sequence exploits the
chemical shift difference between fat and water.61 Separate
“water-only” and “fat-only” images allow for a four class
(lungs, air, soft tissue, and fat) model. Major bones (including
the skull, spine, left/right hip, and left/right upper femur)
with continuous LACs are additionally added through a bone
segmentation algorithm that uses a set of predefined bone
masks and MR images. This is performed through a combi-
nation of landmark-based similarity registration and inten-
sity-based deformable registration. The method is based on
the study by Paulus et al.62
The Philips ingenuity time-of-flight (ToF) scanner has
used a free-breathing 3D spoiled T1-weighted gradient echo
Cartesian MRI sequence46 to segment the lungs. Previously,
three tissue classes (air, lungs, soft tissue) have been used for
whole-body PET/MRI. The underlying segmentation method
(as described by Schulz et al.46) identifies the lungs through a
region growing approach together with automatic threshold
estimation found from an intensity analysis. To illustrate this
segmentation further, in the original study,46 each patient
firstly had one of their coronal slices automatically chosen
based on which had the largest cross section. Using this slice
FIG. 5. Example computed tomography (CT) [Left], magnetic resonance (MR) [Middle], and MR attenuation correction (MRAC) [Right] images of the lungs.
An increase in CT intensity can be seen in the direction of gravity (arrow) but this change in density is not reflected in the MRAC.
FIG. 6. A patient with idiopathic pulmonary fibrosis. High-resolution computed tomography (CT) [Left] shows increased attenuation areas of reticulation, trac-
tion bronchiectasis and ground glass inflammatory changes (black arrows) and low attenuation areas related to obstructive small airways disease (red circle and
surroundings). The T2 Blade high-resolution fat saturation magnetic resonance (MR) image [Middle] acquired at the same level of CT confirms most of the fibro-
tic changes but is unable to define low attenuation areas due to a lack of signal and diminished spatial resolution (MR imaging— 3 mm, compared with high-res-
olution CT — 0.6 mm). The MR attenuation correction map is shown on the right image.
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and nearby coronal slices, an intensity threshold was deter-
mined using the Laplace histogram, and connected clusters
were established by slice restricted region growing. Follow-
ing this analysis, the authors applied a 3D region growing
(intensity threshold based) approach to segment the lungs.
The GE scanner has used a 3D dual-echo RF spoiled
gradient echo sequence (denoted LAVA-FLEX). Four
segmentation classes (air, lung, soft-tissue, and fat) are used
(although bone is added in the head63). The approach is simi-
lar to the Siemens Dixon approach, and the original body
FIG. 7. An example of an artifact in the magnetic resonance attenuation correction (MRAC) map. Positron emission tomography (PET) (top left), MR (top right),
fused PET/MR (bottom left), and MRAC (bottom right) images are displayed. The inaccuracies appear in both the left and right side of the lung, near the dia-
phragm and are pinpointed by arrows.
TABLE I. A brief summary of the three attenuation estimation types.
Method
Segmentation Atlas/Mapping Emission
Example
advantages
• Computationally fast
• Doesn’t require large cross-over datasets
• Continuous LACs
• Considers inter-patient variation
• Continuous LACs
• Computes LACs directly from
emission data
Example
disadvantages
• Mis-segmentation errors in presence of
low signal
• Single-valued LACs
• Often computationally expensive
• Requires large database of multi-
modality data
• Can suffer from cross-talk artifacts
• Tracer dependent
Example citations • Beyer et al.65
• Arabi et al.67
• Marshall et al.68
• Lonn and Wollenweber66
• Chang et al.76
• Lois et al.77
• Arabi and Zaidi85
• Hofmann et al.87
• Arabi and Zaidi73
• Beyer et al.91
• Marshall et al.45
• Salomon et al.100
• Madsen and Lee105
• Berker et al.106
• Mehranian and Zaidi99
• Ahn et al.110
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segmentation method is described by Wollenweber et al.64.
Example MRAC maps previously obtained using various
vendor software are given in Fig. 8. See Beyer et al.65 for fur-
ther details.
The problem with using single-valued lung LACs and the
variation between different vendor methods has been illus-
trated by many different studies. Lonn and Wollenweber66
measured mean whole-lung LACs using CT in a patient
group, and the range of 0.02 to 0.04 cm1 was shown to sub-
stantially change PET activity in reconstruction. Moreover,
Beyer et al.65 established that mean lung LACs are lower for
the SIGNA than the other two PET/MRI scanners. This result
may have been influenced by significant intra-system varia-
tion reported in the segmented lung volume of some patients.
Many studies have analyzed lung quantification in and
across different whole-body vendor segmentation methods.
While the results do not solely show the effect of using sin-
gle-valued lung LACs, the differences reported do strongly
suggest the need for improvement.
Arabi et al.67 compared three and four class segmentation
methods in a 14 oncology patient cohort with cross-over
PET/CT and PET/MRI. Considering six ROIs drawn in the
lung, they reported a significant positive mean SUV lung bias
of 18.6  15.3% for the three class method and low negative
bias of 0.5  13.3% for the four class method, taking PET/
CT as the reference standard. Ouyang et al.51 also analyzed
the potential effect of segmentation using four tissue class
segmentation on 23 PET/CT patients. They computed 15.1%
root mean square error percentage bias in the lungs.
Other reported results are as follows: Marshall et al.68
added bone segmentation to a four tissue class segmentation
in a 12 oncology patient cohort, imaged using both PET/CT
and Turbo-FLASH MRI. The atlas used 121 patient CT scans,
and the authors found that use of the bone atlas slightly
increased mean lung errors from 7.7% to 8% (P = 0.002).
Furthermore, Bezrukov et al.50 compared four class segmen-
tation to an additional bone segmentation (established using
both a pediatric and adult atlas). They demonstrated signifi-
cant variation in the standard deviation of lung SUV (on the
order of 15%) for all three methods relative to CT. Wollenwe-
ber et al.64 also compared four class and three class segmen-
tation in an 18-person PET/CT and MRI cohort. They
reported 14% errors in the lungs. Beyer et al.65 showed that
total lung integral attenuation values differ by up to 10%
across the three systems. While the study was limited in only
using four healthy males, the authors note the challenge with
multi-center studies.
In addition to the use of single-valued LACs, a commonly
encountered problem with the above methods are lung seg-
mentation errors. Bone is often not distinguished as a sepa-
rate class because of its inherently low signal in MRAC
sequences.16 Moreover, air in the stomach and bowel (along
with respiratory and cardiac motion artifacts) can give rise to
poor separation of the lungs at the diaphragm.69 Mis-segmen-
tation occurs for all of these reasons, and Fig. 9 shows an
example. Keereman et al.47 performed XCAT simulations to
analyze the effect of segmentation errors. They determined
that up to 10% of lung to air misclassification can be toler-
ated but that the misclassification of lung to soft-tissue (and
indeed lung to bone) leads to significantly greater errors. In a
similar study, Akbarzadeh et al.70 also undertook non-ToF
XCAT simulations, finding that ignoring bone attenuation
increases PET mean relative error by up to 15% for simulated
lesions in the body.
Susceptibility artifacts, for example, due to metal, for
example, in cardiac stents, can also cause poor segmentation
TABLE II. . Details of specific vendor magnetic resonance attenuation correction (MRAC) sequences. Adapted from Beyer et al.65 Information relevant to the Sie-
mens sequence is also taken from Paulus et al.62
Parameter
Vendor
Siemens Philips General electric
Version Biograph mMR (VB20P) Ingenuity time-of-flight (3.2.2) EMP24.0_EA_1350
Sequence Dixon VIBE Multi-stack spoiled T1w GE LAVA-FLEX
Flip angle (°) 10 10 5
TR (ms) 3.6 4.1 4.0
TE (ms) 2.46 2.3 1.7
Matrix 128 9 192 144 9 144 256 9 128
2.6 9 2.6 mm 4 9 4 mm 4.69 9 4.69 mm
Slice (mm) 2.6 4 2.8
Orientation Head first supine (coronal) Head first supine (axial) Head first supine (axial)
Coils Surface radiofrequency coil Built-in body radio-frequency coil Built-in body radio-frequency coil
Gated Yes No No
Lung LAC (cm1) 0.0240 0.0219 0.0180
Soft tissue LAC (cm1) 0.1000 0.0950 Variable (0.086–0.100)
Fat LAC (cm1) 0.0854 NA Variable (0.086–0.100)
Scan time (s) per bed position 19 24 18
Tissue classes 5 3 5
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with the lung masks becoming continuous with air outside of
the body (Fig. 10). Misclassification artifacts (Fig. 11) also
frequently appear, affecting quantification.
A number of studies have aimed to improve the robustness
of lung segmentation. Hu et al.69,71 used an intensity thresh-
old region growing method with regularization provided by a
deformable shape model. Anatomical MR images were estab-
lished using a T1-weighted 3D fast gradient-echo multi-stack
whole-body sequence. The model consists of a triangle mesh
(3000 triangles) established from 20 high-resolution CT data-
sets. The model is started by very low threshold intensity-
based lung segmentation. The mesh model is then modified
for the patient using an energy minimization scheme. Further
postprocessing is then applied to adjust pointed edges, and a
region growing technique is applied using both an intensity-
and distance-based threshold. Figure 12 shows the improve-
ment gained using a deformable lung model.
Bezrukov et al.17 also combined atlas-based susceptibility
artifact correction with standard four class segmentation to
reduce the effect of susceptibility artifacts. Furthermore,
Shanbhag et al.72 used a spatially adaptive phase field segmen-
tation approach and anatomy context-driven decision making.
Lonn and Wollenweber66 used patient-specific mean
whole-lung LACs determined after correlating mean LAC to
total lung volume (see Fig. 13). Results were compared with
those found using generic single-population LACs, and SUV
errors of up to 10% were reported. Reasons for the remaining
inaccuracy have been suggested to be a result of neglecting
factors including body positioning, pathology, gender, and
age.16 Mean LAC-lung volume correlation has also been con-
sidered by Arabi and Zaidi73 in a multi-atlas technique, as
further discussed in Section 4.C.
In an animal study, Steinberg et al.74 segmented the lungs
using a T1-weighted 3D turbo spin echo thrive sequence with
fixed and region sized thresholds. Furthermore, Chatterjee
et al.75 used a multi-echo ultra-short echo time (UTE)
sequence to generate an MRAC map of a healthy volunteer.
Eight echoes were used to segment the lungs, based on a sig-
nal model that allowed separation of water, fat and the short
T2* lung component. The study was limited by the long-scan
time — ten minutes with respiratory triggering.
As an alternative, Chang et al.76 performed lung seg-
mentation from non-attenuation-corrected PET images in a
three stage process. Stage one involved segmenting the
whole body in the nonattenuation-corrected PET image.
This allowed for an initial attenuation map to be created
that could be used as an input for PET reconstruction. The
lungs could then be coarsely segmented in stage two to
FIG. 8. Example magnetic resonance attenuation correction (MRAC) maps from the three major vendors. Adapted from Beyer et al.65 Note that the Siemens
MRAC images were obtained using the older software version ‘VB18P’, and at this time, bone was not included as a separate tissue class.
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further update the attenuation map. Stage three further
refined the lung segmentation by delineating the heart and
liver from the lung contour. Using an iterative process, the
method took three times as long as an ordinary PET recon-
struction and required some manual interaction. The study
also found attenuation correction differences within the
lung parenchyma, lung-liver, and lung-heart interfaces rela-
tive to CT (see Fig. 14).
Finally, the effect of MRI-contrast agents in LAC estima-
tion still needs to be fully understood in clinical lung MRI,
notably considering the influence of contrast on lung seg-
mentation. Martinez-M€oller and Nekolla4 state that despite
not changing fat/water separation, an increased MRI signal
due to the lowering of lung T1 may influence segmentation.
Moreover, Lois et al.77 reported that ingesting iron oxide-
based oral contrast agent can bias segmented attenuation esti-
mation, for example, resulting in stomach voxels being
assigned to the lung, but that the bias is removed with atlas-
based attenuation estimation or use of an alternative contrast
agent (pineapple juice). These results were only taken from
one patient, so further analysis is required. Other notable
nonlung studies are that of Lee et al.78 who evaluated the
influence of gadolinium MRI-contrast on PET images for
patients with breast cancer, and Borra et al.79 who explored
the effect of susceptibility effects associated with iron oxide
nanoparticles on PET SUV values on the liver, spleen, and
pancreas.
4.B. Techniques accounting for breathing
mismatch
In addition to the previously mentioned techniques, a
number of papers have aimed to reduce the effect of breath-
ing-induced spatial mismatch between MRI-derived attenua-
tion estimation and PET. These can affect both segmentation
methods and the techniques subsequently described in Sec-
tions 4.C and 4.D.
Ai and Pan80 demonstrated the feasibility of using respira-
tion-averaged MRI on one patient. Using a two-dimensional
(2D) multi-slice, multi-phase spoiled gradient-recalled echo
sequence they acquired 12 consecutive time frames at each
slice location to have good coverage over the full respiratory
cycle at each slice location.
Kolbitsch et al.81 also determined a motion-corrected
attenuation map for use in PET simulations. They acquired
MRI data from four volunteers using a 96 s multi-echo acqui-
sition with a 3D Golden radial phase encoding sampling
scheme. Using a self-gating scheme from 1D foot-head pro-
jections they reconstructed 3D images at different respiratory
phases using iterative non-Cartesian SENSE with a general-
ized total-variation constraint in the spatial and temporal
directions. They then used motion fields and fat-water com-
ponent separation to produce a four-class motion-corrected
MRAC map. Kolbitsch et al.82 have also recently published
on MRI-based attenuation correction for motion-compen-
sated cardiac PET/MRI.
In contrast, Buerger et al.83 computed 4D attenuation
maps using two different MRI acquisitions. The first acquisi-
tion was a dual-echo UTE sequence using 0.14 and 4.6 ms
echo times and was used to generate a 3D static four class
MRAC map. The second acquisition involved generating low
FIG. 9. Inaccurate lung segmentation. Adapted from Beyer et al.65
FIG. 10. A susceptibility artifact evident in the chest wall on magnetic resonance imaging (Left, white arrow), the attenuation map (Middle), and the positron
emission tomography (PET) image (Right). The lung appears continuous with the demarcated air pocket in the reconstructed PET image (black arrow).
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resolution (5 9 5 9 1.5 mm) dynamic 3D images with 0.5 s
per frame in order to produce 4D AC maps for 4D PET
reconstruction. The study was limited to PET simulations and
had long MRI scan times (11–16 min).
Finally, Yang et al.84 developed a 4D PET respiratory
phase-matched approach with MRI. An undersampled
Dixon technique was used to repeatedly acquire 3D data
during free-breathing, and this was reconstructed using
compressed sensing. One patient was scanned eight times
with 68Ga-DOTA-TOC PET/MRI and four class MRAC
maps were computed using both an external respiratory
trace and the self-gated 4D images. MRI values were con-
verted to continuous CT values using the weighted sum of
water/fat values. The authors found that PET tumor uptake
values increased in lesions located at the lung-liver inter-
face for both respiratory correction methods, compared
with static MRAC.
4.C. Atlas/mapping techniques
Atlas/mapping techniques are an alternative means of esti-
mating LACs in PET/MRI.
Single or multi-atlas methods generate LACs in the fol-
lowing way, as depicted in Fig. 15.18 An atlas consists of an
MR image and either a corresponding PET transmission or
spatially aligned CT image. To establish a patient-specific
LAC map, the atlas MR image is first warped to the target
MR image, and then the associated deformation (coupled
with appropriate LAC scaling) is applied to the transmission/
CT atlas in order to generate a patient-specific LAC map.
Multiple atlases can be used to generate the most appropriate
patient-specific attenuation correction image.
Such approaches have the advantage of giving continu-
ously valued lung LACs but due to variability in pathology,
the single/multi-atlas database can potentially fail to yield an
FIG. 11. An illustration of tissue misclassification in the lung. The images shown are from a whole-body [18F]-FDG positron emission tomography/magnetic res-
onance imaging (PET/MRI) study of a patient with metastatic lung cancer. Dixon four class segmentation is used with out-of-phase (a), in-phase (b), fat (c), and
water (d) MRI given. Figure (e) shows false air tissue assignment to the lower thorax on the MRAC image. Lung attenuation values are assigned correctly to the
upper thorax. Figure (f) shows the resultant PET emission image showing an area of severe underestimation of PET activity in the lower thorax, a result of the
MR attenuation correction misclassification. Adapted from Keller et al.135
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accurate patient-specific LAC map.16 Registration suffers
from errors due to the nonrigidity of the lung and limitations
in the registration method itself, for example, due to local
minima in the similarity measure.51 Furthermore, multiple
registrations can be computationally expensive, affecting the
method’s clinical feasibility and can be too dependent on the
quality of CT/MRI parameters.19
With the long computation times associated with multiple
nonrigid registrations, Arabi and Zaidi85 aimed to develop a
one-registration approach. Here, precomputed transforma-
tions were established between a reference atlas and the
remaining atlas images. Registration was then performed
between the target image and reference atlas, and using the
precomputed transformations, all atlas images were warped
to the target image. Twenty-three patients undertook both
PET/MRI and PET/CT, and a leave-one-out cross validation
approach was employed. Arithmetic averaging and voxel-
wise weighting (VWW) were performed for atlas fusion.
Voxel-wise weighting outperformed arithmetic averaging for
both the one-registration method and direct registration
approaches. Both methods reduced lung quantification errors
compared with the three-class segmented MRAC. As an
example, VWW following the one-registration approach,
MRAC, and CT exhibited mean lung attenuation values of
794, 770, and 798 HU, respectively. They also deter-
mined that the one-registration technique is approximately a
factor of 1/N (N — Number of atlases) faster than the direct
registration approach and only suffers from moderately worse
errors. Nonetheless, there was still variation in the magnitude
of the relative PET error for both the direct registration
VWW (6.4  5.4%) and one registration VWW
(6.7  6.1%) techniques, relative to PET/CT.
Another variation to increase accuracy and potentially
reduce computational cost has been to use sorted atlas data-
sets. Gender-dependent, body mass index (BMI)-dependent,
and combined BMI and gender-independent atlases were pre-
viously trialled.86 The authors used three BMI categories
(Normal, Overweight, and Obese) and separate male/female
categories. Due to misregistration in the lung, the authors
found PET errors for all methods relative to CT. However,
they determined that using categorized atlases gave smaller
lung errors than not using categorized atlases, with gender
independent atlases giving smaller errors than BMI indepen-
dent atlases.
Another variation to traditional multi-atlas techniques has
been to additionally incorporate machine learning, so as to
map the MRI signal to lung LACs. This has the advantage of
potentially increasing robustness to lung anatomical variabil-
ity and nonrigidity by constraining the registration less.16
Hofmann et al.87 generated continuous lung attenuation
maps by adapting their original atlas/machine learning
approach.88 They used MRI/CT pairs, registering them to the
target MR image as in traditional methods. However, they
used gaussian process regression to estimate the pseudo-CT
of an unknown voxel considering the local neighborhood.
Compared with Hofmann et al.,88 their method for the lung
used a different registration method, a modified kernel func-
tion, and added pre and postprocessing steps. The method
was evaluated with a leave-one-out cross validation approach.
The authors determined mean lung SUV errors
(14.0  11.4%) relative to CT (see Fig. 16). These were
slightly worse than a five class segmented CT
(13.5  10.7%), potentially due to the small dataset size.
FIG. 12. The magnetic resonance image (left), original segmentation (middle), and improved segmentation. Adapted from Hu et al.69
FIG. 13. The correlation between mean lung linear attenuation correction and
total lung volume. Adapted from Lonn and Wollenweber.66
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The approach has been suggested to suffer from high compu-
tation time.16
An updated method has been given by Arabi and Zaidi.73
For nonlung, these authors sort atlas images based on voxel-
wise local normalized cross correlation. This is to find the
best match to the target image, as was originally suggested
for the brain by Burgos et al.89 More importantly for lung,
Arabi and Zaidi73 used a 50 patient CT dataset to incorporate
a mean lung LAC-total lung volume correlation into the
Gaussian process regression kernel, possibly based on the
observation of Lonn and Wollenweber66 (see Section 4.A).
Arabi and Zaidi73 determined that with 14 patients, whole-
lung mean SUV bias fell from 8.9% following Hofmann
et al.87 to 4.1%, relative to PET/CT. These results are shown
in Fig. 17. The study found that both atlas/machine learning
methods had reduced SUV mean error in the lungs, com-
pared with three class MRAC. However, computation time
was long per target image (1100 min) owing to the multiple
registrations and Gaussian process regression training.90
As an alternative, several studies have attempted to per-
form MRI-CT lung mapping, from which LACs can be
generated. Beyer et al.91 employed histogram matching.
Ten oncology patients had PET/CT and contrast-enhanced
transverse T1-weighted VIBE MRI torso scans. The MRI
and CT pairs were co-registered using both mutual infor-
mation and elastic regularization. Histogram matching
involved (a) using the individual pixel intensities in the
MR and CT 2D images to form intensity histograms, (b)
summing the 2D image histograms to form a 3D cumula-
tive histogram, (c) finding matching pairs of CT and MRI
intensities for which the cumulative intensities are equal,
and (d) generating a MRI-CT mapping table from the
matched pairs. The study found PET errors determined in
the lungs were likely due to the lack of anatomical infor-
mation used in the mapping coupled with poor lung MRI
contrast and misregistration.
Alternatively, Marshall et al.45 performed an MRI-CT
mapping animal study, with cross-over PET/CT and two-di-
mensional turbo fast low-angle shot (Turbo-FLASH) MRI. A
three-class tissue model was used where the lungs were seg-
mented using voxel seeding based on an intensity threshold.
The lung pair images were co-registered, and the intensity
values were then correlated using (a) individual voxels, (b)
mean signal intensities of coronal slices (to maintain dorsal
to ventral density gradients), and (c) whole-lung mean signal
intensities. PET reconstructions were then performed using
the derived mappings on the MR images and compared with
reconstructions that assumed constant lung CT attenuation.
Three respiratory states were considered, and Fig. 18 shows
the established correlations.
Marshall et al.45 determined that while all three mappings
led to improved lung PET quantification compared with
using constant lung LACs, the individual voxel mapping gave
highest accuracy. Nonetheless, the lungs were consistently
FIG. 14. Example computed tomography and nonattenuation-corrected positron emission tomography segmentation procedures. Adapted from Chang et al.76
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mis-segmented by approximately 15% in all respiratory
states, and despite segmentation being independent of the
mapping procedure this would have affected the mapping
results. This study was also limited by being on animals who
underwent external ventilation. Furthermore, such a mapping
generally requires a standardized protocol and is influenced
by respiratory motion, diamagnetic susceptibility, and flow-
based artifacts.16
FIG. 15. A depiction of atlas attenuation estimation. Adapted from Hofmann et al.18
FIG. 16. Mean standard uptake value errors in the lung determined by the Hofmann approach (red) and five class segmentation (blue), relative to computed
tomography. Adapted from Hofmann et al.87
Medical Physics, 0 (0), xxxx
14 Lillington et al.: PET/MRI lung attenuation estimation 14
4.D. Emission-based schemes
Emission-based schemes estimate the attenuation image
directly from the emission data and are particularly promising
for overcoming the quantification errors induced by conven-
tional segmentation-based attenuation estimation methods.
Such schemes can be broadly divided into two categories:
analytic and iterative reconstruction types. Analytic methods
estimate the attenuation distribution without having to recon-
struct an activity map and rely on the consistency conditions
of the attenuated Radon transform.92,93 Iterative methods aim
to iteratively reconstruct the attenuation together with the
activity distribution of the object, most commonly with
simultaneous maximum likelihood reconstruction of activity
and attenuation (MLAA), possibly combining a priori knowl-
edge about absolute attenuation values.94 Iterative methods
potentially benefit from modeling the underlying physics of
the process and take into account the Poisson nature of the
data. However, the improvement on analytic approaches
comes at the cost of greater computational demand.
The MLAA method consists of an alternating optimization
approach in which the activity distribution and attenuation
distribution are updated repeatedly. At each step, the problem
can be traced back to either emission95 or transmission
tomography96 reconstruction. However, the joint estimate of
activity and attenuation has been found to be highly ill-posed.
In fact, it suffers from the so called cross-talk artifact, where
errors in the activity estimate are compensated by errors in
the attenuation map. The availability of time-of-flight (ToF)
PET allowed this limitation to be reduced, leading to a more
stable solution of the joint-problem.97 Nevertheless, the atten-
uation image can only be determined up to an unknown off-
set, resulting in an unknown scaling factor in the
reconstructed activity image.98 Overall, the performance of
ToF-MLAA algorithms strongly depends on ToF timing reso-
lution.99 With the advent of ToF-PET/MRI scanners, Salo-
mon et al.100 incorporated segmented MRI information into
the ToF-MLAA estimation of attenuation coefficients. The
segmentation of MRI data is used to distinguish different
regions for the subsequent update of the attenuation values.
The attenuation coefficient of each region was initially pre-
scribed the value of water at 511 keV. Subsequently, ToF-
MLEM (Maximum Likelihood Expectation Maximization)
and a gradient-ascent-based algorithm were used to jointly
update the activity and attenuation values for each region.
The results showed a considerable reduction in noise and
cross-talk artifacts. To reduce the inherent cross-talk of
MLAA, Atibi and Rezaei101 recently proposed to incorporate
a tissue prior atlas (TPA) and a Gibbs prior, representing the
attenuation coefficient estimates as a mixture of pseudo-
Gaussian distributions. The algorithm outperformed the MR-
MLAA algorithm proposed by Heusser et al.102 In addition,
FIG. 17. Mean lung linear attenuation corrections on an individual patient
basis determined from computed tomography (green), the Hofmann approach
(blue), and the Arabi approach. Adapted from Arabi and Zaidi.73
FIG. 18. Computed tomography lung signal as a function of magnetic reso-
nance imaging, derived using individual voxels (a), mean signal intensities of
coronal slices (b), and whole-lung mean signal intensities (c). The three col-
ors represent different breathing states. Adapted from Marshall et al.45
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Rezaei et al.103 evaluated MLAA in ToF PET using a whole-
patient dataset, where the scaling problem in MLAA was
resolved for the evaluation by imposing the total activity of
the MLEM reconstruction. The authors reported a difference
of 7.5%  4.6% between MLAA and MLEM after averag-
ing on several regions of interest, including within the heart,
bladder, liver, and a lumbar vertebra. The same group has
recently evaluated MLAA in ToF PET for brain applica-
tions.104 A uni-modal soft-tissue intensity prior was used in
this work to constrain the reconstructed attenuation. Results
showed that the activity image reconstructed with MLAA is
comparable to an emission reconstruction with a ZTE-based
AC, as well as CT-based AC.
A limited number of studies focus on the derivation of
patient-specific lung attenuation coefficients in emission-
based attenuation estimation methods.
Madsen and Lee105 proposed to use the consistency condi-
tions to refine the lung boundary estimation, previously
obtained from a lung atlas. This is necessary for accurate
lung-liver delineation. The (non-TOF) MLAA framework
was then used to estimate lung (and other whole body) atten-
uation coefficients. This method was only applied to studies
where the arms were not in the field of view (FOV). As sta-
ted, arms in the field of view might increase the difficulty for
determining body contour boundaries.
Berker et al.106 explored a constrained ToF-MLAA algo-
rithm for estimating mean lung LACs using a five-class
whole-body MRAC map as input. The mean lung LAC value
was initially assigned a homogeneous value of either 0 or
0.05 cm1, and the value was subsequently updated while
keeping the remaining tissue LAC values constant. The
results obtained with Monte Carlo simulations showed high
PET quantification bias, possibly due to out-of-FOV coinci-
dences, and the unsolved scaling problem in the MLAA algo-
rithm.
More recently, Mehranian and Zaidi99 proposed to derive
continuous and patient-specific lung LACs from ToF-PET
emission data using the MLAA algorithm. The approach con-
sists of a voxel-wise estimate of the lung LACs, with a conse-
quent improvement over previous methods that only
estimated mean lung attenuation values. In this work, only
the lung values are updated, while the attenuation coefficients
of the other class MRAC maps are assumed to be known.
The objective function used in reconstruction consists of the
Poisson log-likelihood of the data, a Markov random field
smoothing prior, and a Gaussian prior. For the lung, the
Gaussian function was centered at the attenuation coefficient
expectation value of a patient population. The results showed
that the proposed ToF-emission-based algorithm can recover
lung density values, compensate for respiratory-phase mis-
match between PET and CT, and reduce average lung relative
errors, compared with the MRAC method. The approach
assumes that MRI information is sufficiently reliable in other
nonlung regions. However, this is not necessarily the case,
since potential segmentation and classification errors in addi-
tion to uncertainties in tissue attenuation values remain to be
fully addressed.107
It has also been shown that TOF PET reconstruction is less
sensitive than non-TOF to mismatches in the PET and CT
acquisitions.108 Similarly to density changes in PET-CT, the
same consideration would apply for wrong attenuation
assignment by segmentation methods in PET-MRI. In this
regard, Mehranian and Zaidi109demonstrated that TOF-PET
can significantly reduce quantification error in the lung and
bone tissue, due to errors in the MRAC. In the study, the
non-TOF MRAC method achieved an error of
3.4%  11.5% in the lungs and 21.8%  2.9% in bones,
whereas TOF MRAC reduced the error to 2.9%  7.1%
and 15.3%  2.3%, respectively.
Both non-FDG and FDG-based methods involve the
detection of 511-keV annihilation photons, and therefore,
attenuation is not specifically affected by the choice of
radionuclide. However, the distribution in both the activity
and target to background does vary between different radio-
pharmaceuticals/tracers. This will affect the performance of
any emission-based method, including MLAA. For instance,
for 2D TOF PET Defrise et al.97 have shown uniqueness (up
to a global scale factor) of the projections of the attenuation
map for all lines of response with nonzero activity only. This
can lead to problems with the attenuation map estimation
when the activity distribution does not match the spatial
extent of the mu-map. The use and comparison of non-FDG
radionuclides in emission-based studies has been extremely
limited. One study by Ahn et al.110 evaluated a joint estima-
tion of activity and attenuation algorithm using an MR-based
prior both with clinical whole-body non-FDG (68Ga-DOTA-
TOC and 18F-Fluoride) and FDG PET/MRI data. A compar-
ison between FDG and non-FDG performance was not
possible given that no patient received more than one tracer
type. However, the authors did report better lung delineation
using both FDG and the specific and low background uptake
non-FDG tracers, relative to segmented MRAC.
To finish this Section, recent work has indicated that
MLAA can be sensitive to errors in the system modeling111
including timing calibration. Methods to compensate for this
are still under development.112
5. POTENTIAL FUTURE STRATEGIES
Space and complexity constraints make it seem unlikely
that CT or transmission sources will be integrated within clin-
ical PET/MRI scanners for use in routine imaging sessions.
In the absence of this direct measurement, the attenuation
information has to come from either the available PET sig-
nals, MRI signals, prior knowledge, or a combination of
techniques. Based on our experience, this section outlines
seven possible strategies for lung attenuation estimation and
validation.
5.A. Dynamic PET data
PET/MRI offers the potential advantage of simultaneous
dynamic PET and MRI data acquisition. The information
from multiple dynamic PET time frames could then be used
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for improved determination of the LAC estimate. Previously,
Rashidnasab et al.113 have extended the MLAA algorithm to
dynamic MLAA (dMLAA), to jointly reconstruct the activity
distribution and a single attenuation map from dynamic PET
data. The proposed dMLAA alternately estimates the activity
distribution for each time frame, holding the attenuation map
at its current estimate, and then updates the attenuation map
using a maximum likelihood for transmission tomography
(MLTR) approach. The method has been evaluated for
dynamic brain PET data and results show that dMLAA
improves the reconstructed attenuation map compared to
using a single ToF emission frame. Currently, despite the
additional dynamic information, non-ToF reconstruction still
suffers from cross-talk but in the future the concept may be
applied to improve LAC estimates.
5.B. Scattered PET data
Motivated by the fact that attenuation in PET is mainly
due to Compton scattering, and that scatter events represent
up to 40% of the total recorded coincidences, several groups
have considered the possibility of using scattered emission
data as an additional source of information114,115 to overcome
reconstruction ambiguities in MLAA, especially without ToF
data. These attempts share similarities with SPECT stud-
ies,116–118 and extend the earlier suggestion of using individ-
ual photon energy information.119 The idea of deriving
quantitative information from scatter essentially relies on the
possibility of estimating scattering angles through photon
energy measurements, although this is limited by the energy
resolution of the PET detectors.
Previously, Berker and Schulz120 developed the so-called
“scatter-to-attenuation reconstruction algorithm” (S2A).
Their study showed that adding scatter information improves
the quality of the reconstructed activity distribution. This
work relies on the idea that in PET, given detector locations
and the corresponding measured energies for a coincidence,
the set of possible scattering locations can be described geo-
metrically. However, this is only straightforward if energy
measurements of the scattered photons are perfect, as
assumed in this paper. The method relies on a “scatter-to-at-
tenuation” (S2A) back-projection approach. Corrections for
effects such as detector geometry and scatter probabilities are
applied as a multiplicative constant. The work provides a
proof-of-concept investigation into the reconstruction of the
attenuation image from only the scattered data (assuming a
known emission image).
In subsequent years, the group moved from a heuristic
back-projection method to a gradient-ascent optimization
algorithm where the Poisson log-likelihood for data in multi-
ple energy windows is maximized for the attenuation map
with a known emission image.121 Results showed that this
method outperforms S2A, although further development is
necessary to model scatter beyond two dimensions and con-
sider the dependency of attenuation on energy.
The energy resolution of current PET/MRI detector sys-
tems is only around 15%–16% and when dealing with
scattered data, there is a need for more accurate energy reso-
lution modeling. Simulation work by Brusaferri et al.122 indi-
cates that it is possible to obtain an attenuation map from
scattered PET data only (using an energy resolution equal to
16%) even without ToF, albeit at low spatial resolution and
assuming that the emission image is known. Their energy-
based attenuation reconstruction algorithm extends current
methods by incorporating multiple energy window measure-
ments, accurate energy resolution modeling, as well as the
energy dependency of attenuation. A future extension might
be the incorporation of MR information to improve the recon-
structed attenuation map.
5.C. Using single event data to determine the
attenuation sinogram unknown constant
In addition to the potential use of energy information, it
seems logical to also try to use data from singles events.
These could help break the symmetry between activity and
attenuation factors. An iterative algorithm has been devel-
oped123 to reconstruct the activity and attenuation distribution
utilizing ToF data and single events. The algorithm consists
of updating the activity distribution using ToF-MLEM and
updating the attenuation map using MLTR with non-ToF
data. Subsequently, constant coefficients in both activity and
attenuation distribution were corrected with single event data
information. There is potential for future work to take forward
these 2D simulations that used noise-free data where both
scatter and “randoms” information were assumed to be
known.
5.D. MLAA MRI priors
PET/MRI can provide MR data that is spatially and tem-
porally aligned with the PET acquisition and thus might be
useful as subject-specific priors for the PET reconstruction.
Previously, Mehranian et al.124 proposed the incorporation
of a multi-parametric anatomical-functional (MR-PET) prior.
The regularization term consists of a local joint-entropy pen-
alty function that relies on both PET and MRI information. As
the authors stated, the work suggests that the scaling problem
of the MLAA algorithm can be addressed by imposing MRI
spatial constraints on the attenuation estimate. The approach
has been further assessed in a MRI-guided MLAA.125 Results
show that PET images are simultaneously corrected for both
attenuation and the partial volume effect (PVE). The algorithm
outperforms MLAA, enabling noise suppression, and enhanc-
ing boundaries. Nonetheless, these were brain studies, and fur-
ther investigation is needed for the lungs. Furthermore, both
approaches were limited to ToF PET. Another relevant study is
that of Mehranian and Zaidi126 who proposed a MRI-driven
MLAA algorithm in whole-body PET/MR imaging. MR spa-
tial and CT statistical constraints were imposed in the form of
a constrained Gaussian mixture model and a Markov random
field smoothness prior. When compared with other MLAA
algorithms, cross-talk and scaling problems of activity and
attenuation were reduced.
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5.E. MR-CT learning
Machine learning is making rapid advances in many areas.
Viewed as a technique for learning a function from training
data, these methods offer the possibility of learning the rela-
tion between the MR image and the CT and hence the LAC
from a bi-linear scaling of the predicted CT. It has been
shown by Marshall et al.45 that the MR signal does exhibit
some correlation with CT signal. However, there is no clear
direct mapping from MRI to CT and this is where machine/
deep learning may be able to learn additional information
and advance the field.
Learning approaches have shown success in nonlung
attenuation correction, and therefore, they may be of value in
the lung. For example, Nie et al.127 developed a three dimen-
sional fully convolutional neural network approach to gener-
ate pseudo-CT images from MRI data in a patch-based
manner. The authors tested their network on a pelvic dataset
and, their method outperformed atlas, structured random for-
est, and auto-context techniques. Deep learning has also been
applied to lung pattern classification for interstitial lung dis-
eases (ILDs). Using 120 CT scans, Anthimopoulos et al.128
followed a convolutional neural network approach to catego-
rize ILD patterns into seven types, determining an 85.5%
classification success rate. Given that many more studies that
have been published for nonlung attenuation correction, it is
recommended to analyze the previously developed methods
in order to address their suitably for lung MRAC application.
In addition, machine/deep learning may be used in combi-
nation to improve either segmentation or emission-based
attenuation estimation techniques. As an example of this,
albeit not specifically targeted to attenuation estimation,
Gong et al.129 trained a deep residual convolutional neural
network using interpatient information to improve upon a
PET iterative reconstruction framework. They solved a con-
strained optimization problem using an alternating direction
method of multipliers algorithm using six patient PET data-
sets. The proposed method outperformed neural network
denoising and conventional penalized maximum likelihood
methods in the lung, demonstrating higher lesion contrast to
noise ratios. While the approach was solely targeted to PET
images, the authors do state that the model can be applied in
either a CT or MRI framework.
In the lung, the accuracy of attenuation correction learning
will depend on the quality of the underlying image dataset.
When paired MR-CT images are used, learning methods have
been dependent on the registration quality of the dataset
images. Nonetheless, the use of unpaired data may be feasi-
ble, as recently demonstrated by Wolterink et al.130 The
authors developed a generative adversarial network approach,
generating pseudo CT images from two dimensional MRI
brain data with a 24 patient cohort.
Challenges may also arise where MRI lung signal is poor,
resulting in the network having to focus on low level features,
for example, points between images or edges. Here, transfer
learning may be beneficial because using an already trained
model may operate as a good starting framework for
subsequent lung MRI-CT training. This may also be advanta-
geous where small datasets exist. In any approach, the perfor-
mance of different MRI sequences (T1/T2/PD/UTE/ZTE,
etc) and the various scan parameters (resolution, acquisition
time, signal to noise ratio, etc) should be assessed. The size
of the required dataset also needs to be better understood.
Nevertheless, the rapid advances in the field of deep learning
might make it possible to incorporate prior knowledge from
previous data and physics understanding of scattering and
singles to create subject-specific LAC estimates. A notable
study is that of Hwang et al.131 who assessed the ability of
deep convolutional neural networks within MLAA to over-
come limitations of cross-talk, slow convergence speed, and
noisy attenuation maps. The authors applied the method to a
clinical brain dataset and reported decreased noise and
increased uniformity within attenuation maps and also dimin-
ished cross-talk problems for the combined deep learning
method compared with standard MLAA”. Similar results
might be expected within the lung, and moreover, the use of
deep learning to aid reconstruction might also be expected to
contribute to lung reconstruction in the future.
5.F. Registration and deformation of an existing
attenuation map
If an attenuation map is available from a previous CT
study, a possible strategy is to register this to the PET and/or
MR data. In contrast to brain PET/MR where rigid registra-
tion can be used, this needs deformable registration for the
thorax. Nonattenuation-corrected PET images might not con-
tain sufficient information for successful registration in the
thorax, therefore MR images can be used. However, this can
lead to problems with mismatched breathing states between
CT, MR and PET. Recent methods, including maximum-like-
lihood activity reconstruction and attenuation registration
(MLRR), attempt to overcome this problem by estimating the
deformation field based on the PET data.103,132 However,
these approaches currently do not take density changes dur-
ing respiration into account. Moreover, it is difficult to see
these methods becoming widespread in clinical practice due
to the need for a previous scan and the associated data man-
agement issues even if it exists.
5.G. Method validation
A remaining challenge lies in how best to assess potential
lung attenuation estimation methods, both for the inherent
accuracy of the LAC estimate, and the impact upon diagnosis
or treatment monitoring. The lack of available realistic phan-
toms for PET, MRI, and CT limit their use in attenuation esti-
mation, although for example, PET-CT-MRI phantoms have
been proposed containing four representative tissue types,
with the lung section being based on a pig lung lobe.133
Patient cross-over studies where both PET/CT and PET/MRI
data are available from the same patient are informative,
though have limitations in terms of accuracy of image regis-
tration and lung density changes due to differences in
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breathing and patient repositioning. Furthermore, the litera-
ture has mixed opinion on whether PET transmission or CT-
based attenuation estimation should be considered as the ref-
erence standard. Inaccuracies in the LAC estimate will affect
the PET quantification but the impact of this is application
specific. There may be higher LAC accuracy requirements
for applications requiring an absolute SUV value, for exam-
ple, the monitoring of a treatment response, or decisions
based upon a threshold SUV, compared to applications where
a relative change in SUV is adequate.
Additional variability can arise from different PET recon-
struction parameters, registration algorithms, FOV truncation
compensation,134 MR-coils, SUV error types (mean vs maxi-
mum or whole-lung vs a voxel basis), and patient diseases. A
better consensus and more lung-specifically targeted studies
would be of great benefit for future applications of lung PET/
MRI.
6. CONCLUSION
Despite the potential of PET/MRI for whole-body imaging
and pulmonary studies, lung attenuation estimation has been
an under-appreciated problem. This review has identified the
key challenges associated with determining lung attenuation
maps. It has highlighted some of the issues by examining past
and present methods for estimating lung linear attenuation
coefficients (LACs). Current commercial practice is to
employ single-valued population-based LACs following seg-
mentation of MR images. The use of single-values impacts
PET quantification because underlying lung LACs vary both
on an individual basis and from person to person. Commer-
cial roadmaps are not usually made public, but it is hoped
that vendors will be able to implement techniques that lead to
improved lung quantification. With active developments tak-
ing place, it is difficult to predict the techniques that will be
adopted in the future, though a combination of improved
MRI acquisitions and machine learning or MLAA
approaches are currently looking promising. Hopefully
advances will lead to clinically available systems that can
offer information with high diagnostic or prognostic value for
patients.
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